List of Studies ( Metabolite:24,25-Dihydrolanosterol)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST000450 | AN000705 | Metabolic features of chronic fatigue syndrome | Blood | Human | Myalgic encephalomyelitis/chronic fatigue syndrome | University of California, San Diego | Area under curve |
ST000465 | AN000727 | Uniquely Tumor-Selective Englerin A Profoundly Alters Lipid Metabolism in Renal Cell Carcinoma inducing ER-Stress and an Acute Inflammatory Response | Kidney | Human | Cancer | University of California, San Diego | Area under curve |
ST000617 | AN000947 | Validation of the application of targeted metabolomic appraoch in the diagnosis of CFS | Blood | Human | Myalgic encephalomyelitis/chronic fatigue syndrome | University of California, San Diego | Area under curve |
ST000915 | AN001486 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver | Liver | Human | Fatty liver disease | LIPID MAPS | nmol/mg |
ST001780 | AN002890 | Comparative analysis of metabolomic profiles in cerebrospinal fluid before and after endurance exercise | Cerebrospinal fluid | Human | UCSD School of Medicine | peak area | |
ST001789 | AN002901 | Acute metabolomic changes of plasma in response to endurance exercise | Blood | Human | University of California, San Diego | peak area | |
ST001937 | AN003150 | Comprehensive plasma metabolomics and lipidomics based management of benign and malignant solitary pulmonary nodules | Blood | Human | Cancer | China Pharmaceutical University | peak height |
ST000916 | AN001492 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma | Blood | Human | Fatty liver disease | LIPID MAPS | uM |